Tommy Summe
Family Medicine · Edmonds, WANPI 1750393666
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 622 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,794 and has fallen 92.7% since, to $277 in 2025. Among family medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 622 payments — averaging $20.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orexo US, Inc.$2K
- AstraZeneca$2K
- Gilead$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Novo Nordisk$960
- AbbVie$779
- plus $5K from 32 others
What the payments were for
- Food & beverage$12,543100%
- Education$350%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orexo US, Inc. | 101 | $1,648 |
| AstraZeneca | 65 | $1,639 |
| Gilead | 42 | $1,144 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 60 | $1,108 |
| Novo Nordisk | 45 | $960 |
| AbbVie(2 entities) | 27 | $779 |
| Zyla Life Sciences, Inc. | 56 | $758 |
| Johnson & Johnson | 23 | $592 |
| Pfizer | 17 | $408 |
| Teva Pharmaceuticals USA, Inc. | 38 | $390 |
| Lilly USA, LLC | 16 | $382 |
| Assertio Therapeutics, Inc. | 18 | $325 |
| Amarin Pharma, Inc. | 11 | $314 |
| Boehringer Ingelheim | 13 | $305 |
| Merck | 9 | $303 |
| Antares Pharma, Inc. | 24 | $249 |
| Indivior Inc. | 6 | $174 |
| Alkermes, Inc. | 3 | $151 |
| Mannkind Corporation | 9 | $136 |
| Biohaven Pharmaceuticals, Inc. | 6 | $118 |
| Kowa Pharmaceuticals America, Inc. | 4 | $116 |
| Amgen(2 entities) | 4 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| Kaleo, Inc. | 3 | $58 |
| Edwards Lifesciences | 2 | $47 |
| MDD US Operations, LLC | 2 | $46 |
| Currax Pharmaceuticals LLC | 2 | $33 |
| Optinose US, Inc. | 2 | $33 |
| Neurelis, Inc. | 1 | $31 |
| Arbor Pharmaceuticals, Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Sentynl Therapeutics, Inc. | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| GSK | 1 | $17 |
| Bayer | 1 | $17 |
| Janssen Scientific Affairs, LLC | 1 | $16 |
| Almatica Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,578 in reported general payments places this provider in the 95th percentile of 2,275 family medicine providers in Washington.
Other family medicine in Edmonds
- Kevin HatfieldSeattle$527K
- Marta KazymyraBlaine$222K
- Donella YoungDavenport$175K
- Robert McIntyreSeattle$107K
- James MorenBellingham$106K
- Marshall BrownPasco$70K
- Cynthia CoteMaple Valley$66K
- Greg LedgerwoodBrewster$66K
- Daniel RivasBurien$50K
- Kent WalkerSumner$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.